Skip to content

Inari Medical, Inc.

CIK 0001531048

← back to feed
Revenue (TTM)
$568.77M
+28.7% YoY Q3 Oct 2024
Net Income (TTM)
−$70.76M
+94.4% YoY Q3 Oct 2024
EPS Diluted (TTM)
−$1.22
+94.5% YoY Q3 Oct 2024
Gross Margin
87.1%
Q3 Oct 2024
Operating Margin
-9.0%
Q3 Oct 2024
Net Margin
-12.4%
Q3 Oct 2024
Free Cash Flow (TTM)
−$20.86M
Q3 Oct 2024
Cash
$41.14M
Q3 Oct 2024
Total Debt
$29.58M
Q3 Oct 2024
Shares Outstanding
58.54M sh
Q3 Oct 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings